| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
1e-08 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-07 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-06 |
| mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-05 |